From New Mechanisms to New Standards of Care
Latest News
News / 20 Sep 2018
Financial Results for Second Quarter Ended 31 July 2018
News / 14 Sep 2018
Summit Therapeutics to Participate in Upcoming Investor Conferences
News / 14 Sep 2018
Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2018 on 20 September 2018
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer
For Investors
Visit our dedicated section for investors that contains the latest available financial and regulatory information
Latest Event
Watch our webcast presentation at the Rodman & Renshaw Global Investment Conference
Our Discuva Platform
Our technology platform is at the heart of our research to develop new mechanism antibiotics